Achieve Mastery of Medical Concepts

Study for medical school and boards with Lecturio

Gout (Clinical)

Gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or "gout flare," followed later by chronic deforming arthritis. Gout is a heterogeneous metabolic disease associated with elevated serum uric acid Uric acid An oxidation product, via xanthine oxidase, of oxypurines such as xanthine and hypoxanthine. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals urate oxidase further oxidizes it to allantoin. Nephrolithiasis levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis Arthritis Acute or chronic inflammation of joints. Osteoarthritis, or “ gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or "gout flare," followed later by chronic deforming arthritis. Gout flare,” followed later by chronic deforming arthritis Arthritis Acute or chronic inflammation of joints. Osteoarthritis. The kidneys Kidneys The kidneys are a pair of bean-shaped organs located retroperitoneally against the posterior wall of the abdomen on either side of the spine. As part of the urinary tract, the kidneys are responsible for blood filtration and excretion of water-soluble waste in the urine. Kidneys: Anatomy can also be affected, and urate crystals can precipitate as chalkstone-like deposits (“ tophi Tophi Msu deposit in the soft tissue and synovium. Gout”) in the soft tissues, synovial tissues, or in bones near the joints. Hyperuricemia Hyperuricemia Excessive uric acid or urate in blood as defined by its solubility in plasma at 37 degrees c; greater than 0. 42 mmol per liter (7. 0 mg/dl) in men or 0. 36 mmol per liter (6. 0 mg/dl) in women. Gout is due to overproduction and/or underexcretion of uric acid Uric acid An oxidation product, via xanthine oxidase, of oxypurines such as xanthine and hypoxanthine. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals urate oxidase further oxidizes it to allantoin. Nephrolithiasis and is a necessary but insufficient precondition to developing urate crystal deposition disease (most hyperuricemic individuals never experience clinical gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or "gout flare," followed later by chronic deforming arthritis. Gout). The most commonly involved joint is the first metatarsophalangeal joint Metatarsophalangeal Joint Foot: Anatomy. The identification Identification Defense Mechanisms of urate crystals in joint aspirate or tophi Tophi Msu deposit in the soft tissue and synovium. Gout is diagnostic. Effective therapies to relieve the pain Pain An unpleasant sensation induced by noxious stimuli which are detected by nerve endings of nociceptive neurons. Pain: Types and Pathways of a gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or "gout flare," followed later by chronic deforming arthritis. Gout flare include nonsteroidal anti-inflammatory drugs ( NSAIDs NSAIDS Primary vs Secondary Headaches), colchicine Colchicine A major alkaloid from colchicum autumnale l. And found also in other colchicum species. Its primary therapeutic use is in the treatment of gout. Gout Drugs, and glucocorticoids Glucocorticoids Glucocorticoids are a class within the corticosteroid family. Glucocorticoids are chemically and functionally similar to endogenous cortisol. There are a wide array of indications, which primarily benefit from the antiinflammatory and immunosuppressive effects of this class of drugs. Glucocorticoids; the choice of therapy depends on the individual and if there are any contraindications Contraindications A condition or factor associated with a recipient that makes the use of a drug, procedure, or physical agent improper or inadvisable. Contraindications may be absolute (life threatening) or relative (higher risk of complications in which benefits may outweigh risks). Noninvasive Ventilation.

Last updated: Mar 4, 2024

Editorial responsibility: Stanley Oiseth, Lindsay Jones, Evelin Maza

Epidemiology and Etiology

Epidemiology[2,3]

  • In the United States, the general prevalence Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from incidence, which refers to the number of new cases in the population at a given time. Measures of Disease Frequency is approximately 3%.
  • Risk increases with higher body mass index Body mass index An indicator of body density as determined by the relationship of body weight to body height. Bmi=weight (kg)/height squared (m2). Bmi correlates with body fat (adipose tissue). Their relationship varies with age and gender. For adults, bmi falls into these categories: below 18. 5 (underweight); 18. 5-24. 9 (normal); 25. 0-29. 9 (overweight); 30. 0 and above (obese). Obesity ( BMI BMI An indicator of body density as determined by the relationship of body weight to body height. Bmi=weight (kg)/height squared (m2). Bmi correlates with body fat (adipose tissue). Their relationship varies with age and gender. For adults, bmi falls into these categories: below 18. 5 (underweight); 18. 5-24. 9 (normal); 25. 0-29. 9 (overweight); 30. 0 and above (obese). Obesity): prevalence Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from incidence, which refers to the number of new cases in the population at a given time. Measures of Disease Frequency is 1%2% in those with normal body mass index Body mass index An indicator of body density as determined by the relationship of body weight to body height. Bmi=weight (kg)/height squared (m2). Bmi correlates with body fat (adipose tissue). Their relationship varies with age and gender. For adults, bmi falls into these categories: below 18. 5 (underweight); 18. 5-24. 9 (normal); 25. 0-29. 9 (overweight); 30. 0 and above (obese). Obesity ( BMI BMI An indicator of body density as determined by the relationship of body weight to body height. Bmi=weight (kg)/height squared (m2). Bmi correlates with body fat (adipose tissue). Their relationship varies with age and gender. For adults, bmi falls into these categories: below 18. 5 (underweight); 18. 5-24. 9 (normal); 25. 0-29. 9 (overweight); 30. 0 and above (obese). Obesity), and 5%7% with class II or class III obesity Obesity Obesity is a condition associated with excess body weight, specifically with the deposition of excessive adipose tissue. Obesity is considered a global epidemic. Major influences come from the western diet and sedentary lifestyles, but the exact mechanisms likely include a mixture of genetic and environmental factors. Obesity
  • Middle-aged to elderly men and postmenopausal women are most often affected.
  • Rare in childhood unless there is an inherited enzyme defect or a malignancy Malignancy Hemothorax

Etiology[1,3,15]

  • Hyperuricemia Hyperuricemia Excessive uric acid or urate in blood as defined by its solubility in plasma at 37 degrees c; greater than 0. 42 mmol per liter (7. 0 mg/dl) in men or 0. 36 mmol per liter (6. 0 mg/dl) in women. Gout ( plasma Plasma The residual portion of blood that is left after removal of blood cells by centrifugation without prior blood coagulation. Transfusion Products urate > 6.8 mg/dL) is necessary but not sufficient for the development of gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout.
    • Only 10% of individuals with hyperuricemia Hyperuricemia Excessive uric acid or urate in blood as defined by its solubility in plasma at 37 degrees c; greater than 0. 42 mmol per liter (7. 0 mg/dl) in men or 0. 36 mmol per liter (6. 0 mg/dl) in women. Gout develop gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout.
    • Elevated uric acid Uric acid An oxidation product, via xanthine oxidase, of oxypurines such as xanthine and hypoxanthine. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals urate oxidase further oxidizes it to allantoin. Nephrolithiasis (UA) can result from reduced excretion (90%), overproduction, or both.
  • Gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout can occur in primary or secondary forms:
    • Primary gout Primary Gout Gout (90%):
      • Unknown enzyme defects: usually due to decreased excretion of UA
      • Known enzyme defects: e.g., Lesch-Nyhan syndrome Lesch-Nyhan syndrome An inherited disorder transmitted as a sex-linked trait and caused by a deficiency of an enzyme of purine metabolism; hypoxanthine phosphoribosyltransferase. Elevation of uric acid in the serum leads to the development of renal calculi and gouty arthritis. Purine Salvage Deficiencies and variants of hypoxanthine-guanine phosphoribosyltransferase deficiency (due to increased purine production), glycogen storage diseases Glycogen Storage Diseases A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement. Benign Liver Tumors (due to decreased excretion of UA) 
    • Secondary gout Secondary Gout Gout (10%):
      • Increased nucleic acid turnover (e.g., leukemia), due to increased UA production
      • Chronic renal disease (due to decreased excretion of UA)

Risk factors that increase UA levels[2,3,15,20]

  • Diets:
    • Rich in meat and seafood 
    • Beverages containing fruit sugar (fructose), alcohol
  • Obesity Obesity Obesity is a condition associated with excess body weight, specifically with the deposition of excessive adipose tissue. Obesity is considered a global epidemic. Major influences come from the western diet and sedentary lifestyles, but the exact mechanisms likely include a mixture of genetic and environmental factors. Obesity
  • Medical conditions: untreated high blood pressure, diabetes Diabetes Diabetes mellitus (DM) is a metabolic disease characterized by hyperglycemia and dysfunction of the regulation of glucose metabolism by insulin. Type 1 DM is diagnosed mostly in children and young adults as the result of autoimmune destruction of β cells in the pancreas and the resulting lack of insulin. Type 2 DM has a significant association with obesity and is characterized by insulin resistance. Diabetes Mellitus, metabolic syndrome Metabolic syndrome Metabolic syndrome is a cluster of conditions that significantly increases the risk for several secondary diseases, notably cardiovascular disease, type 2 diabetes, and nonalcoholic fatty liver. In general, it is agreed that hypertension, insulin resistance/hyperglycemia, and hyperlipidemia, along with central obesity, are components of the metabolic syndrome. Metabolic Syndrome, heart and kidney diseases
  • Certain medications
    • Thiazide Thiazide Heterocyclic compounds with sulfur and nitrogen in the ring. This term commonly refers to the benzothiadiazines that inhibit sodium-potassium-chloride symporters and are used as diuretics. Hyponatremia diuretics Diuretics Agents that promote the excretion of urine through their effects on kidney function. Heart Failure and Angina Medication
    • Low-dose aspirin Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. Nonsteroidal Antiinflammatory Drugs (NSAIDs) 
    • Anti-rejection/ immunosuppressive drugs Immunosuppressive drugs Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of interleukins and other cytokines are emerging. Organ Transplantation used in organ transplantation Organ Transplantation Transplantation is a procedure that involves the removal of an organ or living tissue and placing it into a different part of the body or into a different person. Organ transplantations have become the therapeutic option of choice for many individuals with end-stage organ failure. Organ Transplantation
  • Family history Family History Adult Health Maintenance of gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout
  • Age and sex Sex The totality of characteristics of reproductive structure, functions, phenotype, and genotype, differentiating the male from the female organism. Gender Dysphoria: higher prevalence Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from incidence, which refers to the number of new cases in the population at a given time. Measures of Disease Frequency in middle-aged and older men, but UA levels in postmenopausal women approach those of men
  • Recent surgery or trauma
  • Dehydration Dehydration The condition that results from excessive loss of water from a living organism. Volume Depletion and Dehydration

Mnemonic

Drugs causing acute precipitation of gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout: FACT

F: Furosemide diuretics Diuretics Agents that promote the excretion of urine through their effects on kidney function. Heart Failure and Angina Medication

A: Aspirin/Alcohol

C: Anti-Cancer drugs (e.g., cyclosporine Cyclosporine A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. Immunosuppressants)

T: Thiazide diuretics Diuretics Agents that promote the excretion of urine through their effects on kidney function. Heart Failure and Angina Medication

Pathophysiology

  • Purine compounds, whether they are synthesized in the body or come from eating high-purine foods, can uric acid Uric acid An oxidation product, via xanthine oxidase, of oxypurines such as xanthine and hypoxanthine. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals urate oxidase further oxidizes it to allantoin. Nephrolithiasis levels.[1,16,18]
  • Uric acid Uric acid An oxidation product, via xanthine oxidase, of oxypurines such as xanthine and hypoxanthine. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals urate oxidase further oxidizes it to allantoin. Nephrolithiasis is excreted mainly through the kidneys Kidneys The kidneys are a pair of bean-shaped organs located retroperitoneally against the posterior wall of the abdomen on either side of the spine. As part of the urinary tract, the kidneys are responsible for blood filtration and excretion of water-soluble waste in the urine. Kidneys: Anatomy.
  • Overproduction or underexcretion (more common) of uric acid Uric acid An oxidation product, via xanthine oxidase, of oxypurines such as xanthine and hypoxanthine. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals urate oxidase further oxidizes it to allantoin. Nephrolithiasis can lead to hyperuricemia Hyperuricemia Excessive uric acid or urate in blood as defined by its solubility in plasma at 37 degrees c; greater than 0. 42 mmol per liter (7. 0 mg/dl) in men or 0. 36 mmol per liter (6. 0 mg/dl) in women. Gout → supersaturation → deposition of monosodium urate (MSU) crystals in the tissues
  • MSU deposits in the soft tissue Soft Tissue Soft Tissue Abscess and synovium as MSUcrystals ( tophi Tophi Msu deposit in the soft tissue and synovium. Gout).
    • Can erode the bone Bone Bone is a compact type of hardened connective tissue composed of bone cells, membranes, an extracellular mineralized matrix, and central bone marrow. The 2 primary types of bone are compact and spongy. Bones: Structure and Types and damage other tissues such as tendons and cartilage Cartilage Cartilage is a type of connective tissue derived from embryonic mesenchyme that is responsible for structural support, resilience, and the smoothness of physical actions. Perichondrium (connective tissue membrane surrounding cartilage) compensates for the absence of vasculature in cartilage by providing nutrition and support. Cartilage: Histology
    • Cause recurrent monoarticular arthritis Monoarticular Arthritis Septic Arthritis and chronic deforming arthritis Arthritis Acute or chronic inflammation of joints. Osteoarthritis 
  • The precise relationship between hyperuricemia Hyperuricemia Excessive uric acid or urate in blood as defined by its solubility in plasma at 37 degrees c; greater than 0. 42 mmol per liter (7. 0 mg/dl) in men or 0. 36 mmol per liter (6. 0 mg/dl) in women. Gout and gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout is unclear:
    • The majority (90%) of people with hyperuricemia Hyperuricemia Excessive uric acid or urate in blood as defined by its solubility in plasma at 37 degrees c; greater than 0. 42 mmol per liter (7. 0 mg/dl) in men or 0. 36 mmol per liter (6. 0 mg/dl) in women. Gout do not have gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout.
    • Normal or ↓ serum uric acid Uric acid An oxidation product, via xanthine oxidase, of oxypurines such as xanthine and hypoxanthine. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals urate oxidase further oxidizes it to allantoin. Nephrolithiasis levels do not rule out gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout.
    • However, all patients Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clinician–Patient Relationship with gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout will have hyperuricemia Hyperuricemia Excessive uric acid or urate in blood as defined by its solubility in plasma at 37 degrees c; greater than 0. 42 mmol per liter (7. 0 mg/dl) in men or 0. 36 mmol per liter (6. 0 mg/dl) in women. Gout (> 6.8 mg/dL) at some point, although levels may fluctuate.

Clinical Presentation

Gout flares Gout Flares Gout[3,4,18,20]

  • Typically monoarticular (< 20% are polyarticular)
  • Commonly occurs in the lower extremities, most often at the base of the great toe (first metatarsophalangeal [MTP] joint, or podagra) or the knee
  • Intensely inflammatory, causing severe pain Pain An unpleasant sensation induced by noxious stimuli which are detected by nerve endings of nociceptive neurons. Pain: Types and Pathways, redness Redness Inflammation, warmth, swelling Swelling Inflammation, and disability Disability Determination of the degree of a physical, mental, or emotional handicap. The diagnosis is applied to legal qualification for benefits and income under disability insurance and to eligibility for social security and workman’s compensation benefits. ABCDE Assessment
  • Peaking within 1224 hours and resolving within 310 days even without treatment
  • Onset more often at night

Intercritical gout Intercritical Gout Gout[3,18]

Upon resolution of an acute gout Acute Gout Gout flare, patients Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clinician–Patient Relationship enter an intercritical (between-flares) period.

  • Most often entirely asymptomatic
  • Variable Variable Variables represent information about something that can change. The design of the measurement scales, or of the methods for obtaining information, will determine the data gathered and the characteristics of that data. As a result, a variable can be qualitative or quantitative, and may be further classified into subgroups. Types of Variables in duration
  • Most patients Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clinician–Patient Relationship left untreated will develop a recurrent flare within 2 years.
  • Monosodium urate crystals Monosodium Urate Crystals Gout may continue to deposit as tophi Tophi Msu deposit in the soft tissue and synovium. Gout in various tissues.

Tophaceous gout Tophaceous gout Nodular deposit of monosodium urate crystals associated with chronic inflammation with a foreign-body giant cell reaction. Gout[3,4]

  • Nodular deposit of monosodium urate crystals Monosodium Urate Crystals Gout associated with chronic inflammation Chronic Inflammation Inflammation with a foreign-body giant cell reaction
  • Found in cartilage Cartilage Cartilage is a type of connective tissue derived from embryonic mesenchyme that is responsible for structural support, resilience, and the smoothness of physical actions. Perichondrium (connective tissue membrane surrounding cartilage) compensates for the absence of vasculature in cartilage by providing nutrition and support. Cartilage: Histology, subcutaneous and periarticular tissues, tendons (e.g., Achilles tendon), olecranon Olecranon A prominent projection of the ulna that articulates with the humerus and forms the outer protuberance of the elbow joint. Arm: Anatomy bursae, ear helix, kidney, and elsewhere
  • Can cause destruction of bone Bone Bone is a compact type of hardened connective tissue composed of bone cells, membranes, an extracellular mineralized matrix, and central bone marrow. The 2 primary types of bone are compact and spongy. Bones: Structure and Types and soft tissue Soft Tissue Soft Tissue Abscess

Associated renal complications[3,4,12]

  • Nephrolithiasis Nephrolithiasis Nephrolithiasis is the formation of a stone, or calculus, anywhere along the urinary tract caused by precipitations of solutes in the urine. The most common type of kidney stone is the calcium oxalate stone, but other types include calcium phosphate, struvite (ammonium magnesium phosphate), uric acid, and cystine stones. Nephrolithiasis
  • Chronic urate nephropathy Chronic Urate Nephropathy Gout

Related videos

Diagnosis

Assessment[11]

  • Take a detailed medical history and ask about:
    • Current symptoms:
      • Joints affected
      • Symptom severity and speed of onset 
      • Frequency and duration of attacks 
      • Previous attacks and drug intervention 
      • Dietary habits 
      • Ability to mobilize; impact on work and activities of daily living 
      • Family history Family History Adult Health Maintenance of gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout, hyperuricemia Hyperuricemia Excessive uric acid or urate in blood as defined by its solubility in plasma at 37 degrees c; greater than 0. 42 mmol per liter (7. 0 mg/dl) in men or 0. 36 mmol per liter (6. 0 mg/dl) in women. Gout, nephrolithiasis Nephrolithiasis Nephrolithiasis is the formation of a stone, or calculus, anywhere along the urinary tract caused by precipitations of solutes in the urine. The most common type of kidney stone is the calcium oxalate stone, but other types include calcium phosphate, struvite (ammonium magnesium phosphate), uric acid, and cystine stones. Nephrolithiasis, or renal disease 
      • Comorbidities Comorbidities The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival. St. Louis Encephalitis Virus and risk factors (see above)
  • Examine, paying particular attention Attention Focusing on certain aspects of current experience to the exclusion of others. It is the act of heeding or taking notice or concentrating. Psychiatric Assessment to:
    • Warm, red, swollen joints 
    • Tophi Tophi Msu deposit in the soft tissue and synovium. Gout 
  • Always rule out the possibility of septic arthritis Arthritis Acute or chronic inflammation of joints. Osteoarthritis:
    • Refer immediately to relevant specialists, typically trauma and orthopedics

Evaluation[3,4,11,20]

  • Diagnosis is established via microscopic analysis of the joint aspirate, which shows:
    • Crystals of MSU, which are negatively birefringent (yellow when parallel to compensator filter) and needle-shaped
    • WBC > 2,000/μL with > 50% neutrophils Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. Innate Immunity: Phagocytes and Antigen Presentation (an acute inflammatory synovial fluid)
    • Note: MSU crystals MSU crystals Gout can also be seen on aspirates of tophi Tophi Msu deposit in the soft tissue and synovium. Gout.
  • Laboratory studies may show:
    • ↑ Serum urate:
      • Hyperuricemia Hyperuricemia Excessive uric acid or urate in blood as defined by its solubility in plasma at 37 degrees c; greater than 0. 42 mmol per liter (7. 0 mg/dl) in men or 0. 36 mmol per liter (6. 0 mg/dl) in women. Gout is defined as a concentration > 6.8 mg/dL (405 µmol/L)
      • May be normal or ↓ during an acute flare
      • Best to measure 2 weeks after flare
    • ↑ WBC
    • Erythrocyte sedimentation rate Erythrocyte Sedimentation Rate Soft Tissue Abscess ( ESR ESR Soft Tissue Abscess)
  • X-ray X-ray Penetrating electromagnetic radiation emitted when the inner orbital electrons of an atom are excited and release radiant energy. X-ray wavelengths range from 1 pm to 10 nm. Hard x-rays are the higher energy, shorter wavelength x-rays. Soft x-rays or grenz rays are less energetic and longer in wavelength. The short wavelength end of the x-ray spectrum overlaps the gamma rays wavelength range. The distinction between gamma rays and x-rays is based on their radiation source. Pulmonary Function Tests:
  • Ultrasonography:
    • Hyperechoic Hyperechoic A structure that produces a high-amplitude echo (lighter grays and white) Ultrasound (Sonography) enhancement of the surface of articular cartilage Cartilage Cartilage is a type of connective tissue derived from embryonic mesenchyme that is responsible for structural support, resilience, and the smoothness of physical actions. Perichondrium (connective tissue membrane surrounding cartilage) compensates for the absence of vasculature in cartilage by providing nutrition and support. Cartilage: Histology → MSU crystal deposition
    • MSU crystals MSU crystals Gout may also appear as hyperechoic Hyperechoic A structure that produces a high-amplitude echo (lighter grays and white) Ultrasound (Sonography) foci floating within the joint space
Monosodium urate crystals in elbow joint fluid - gout

Monosodium urate crystals, negatively birefringent (appearing as needle-like yellow crystals when parallel to the polarizing light with a red compensator, and blue when perpendicular), from a patient’s joint aspirate. This finding is diagnostic of gout.

Image: “Monosodium Urate Crystals in Elbow Joint Fluid” by Ed Uthman. License: CC BY 2.0

American College of Rheumatology (ACR) criteria[11,14]

  • Entry criterion: ≥ 1 episode of pain Pain An unpleasant sensation induced by noxious stimuli which are detected by nerve endings of nociceptive neurons. Pain: Types and Pathways, swelling Swelling Inflammation, and/or tenderness in a peripheral joint or bursa
  • Sufficient criteria (either):
    • MSU crystals MSU crystals Gout in joint fluid
    • MSU crystal identified from tophus 
  • If sufficient criteria not met MET Preoperative Care, the following are assessed:
    • Pattern of joint/bursa involvement
    • Characteristics of episodes (e.g., erythema Erythema Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes. Chalazion, unable to bear touch/pressure, difficulty using joint)
    • Number of episodes meeting time-course criteria
    • Evidence of tophi Tophi Msu deposit in the soft tissue and synovium. Gout
    • Serum urate level
    • Synovial fluid analysis Synovial Fluid Analysis Rheumatoid Arthritis
    • Imaging demonstrating urate deposition
    • Imaging demonstrating joint damage 
  • Calculator

Management of Acute Gout

The goal of management is to reduce inflammation Inflammation Inflammation is a complex set of responses to infection and injury involving leukocytes as the principal cellular mediators in the body’s defense against pathogenic organisms. Inflammation is also seen as a response to tissue injury in the process of wound healing. The 5 cardinal signs of inflammation are pain, heat, redness, swelling, and loss of function. Inflammation. Acute episodes should be treated as soon as possible.

Management can vary depending on practice location. The following information is based on US, European, and UK literature and guidelines.

General measures

Symptom relief:[6,9] 

  • Consider acetaminophen Acetaminophen Acetaminophen is an over-the-counter nonopioid analgesic and antipyretic medication and the most commonly used analgesic worldwide. Despite the widespread use of acetaminophen, its mechanism of action is not entirely understood. Acetaminophen ( paracetamol paracetamol Acetaminophen is an over-the-counter nonopioid analgesic and antipyretic medication and the most commonly used analgesic worldwide. Despite the widespread use of acetaminophen, its mechanism of action is not entirely understood. Acetaminophen) as an adjunct for pain Pain An unpleasant sensation induced by noxious stimuli which are detected by nerve endings of nociceptive neurons. Pain: Types and Pathways relief. 
  • Ice packs can provide relief from painful, swollen joints. 
  • Rest and elevate painful limb.

Patient education:[6,9,10,17,21] 

  • Offer lifestyle advice:
    • Lose weight, if overweight.
    • Reduce intake of:
      • Alcohol
      • Sugary or high-fructose corn syrup–containing drinks
      • Meat 
      • Seafood 
    • Avoid dehydration Dehydration The condition that results from excessive loss of water from a living organism. Volume Depletion and Dehydration.
  • Explain that gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout is a lifelong disease that will progress without treatment. 
  • Direct patients Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clinician–Patient Relationship to (depends on location):
    • Sources of information
    • Local support groups
    • Online forums 
    • National charities 

Medical management

Prescribing principles:[6,9,17,21]

  • The decision about medication class must take into account:
    • Individual preferences
    • Comorbidities Comorbidities The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival. St. Louis Encephalitis Virus 
    • Other medications
  • Consider combination therapy if response to monotherapy is inadequate. 
  • Note on antihyperuricemic drugs ( allopurinol Allopurinol A xanthine oxidase inhibitor that decreases uric acid production. It also acts as an antimetabolite on some simpler organisms. Gout Drugs and febuxostat Febuxostat A thiazole derivative and inhibitor of xanthine oxidase that is used for the treatment of hyperuricemia in patients with chronic gout. Gout Drugs):
    • If already prescribed, then it is safe to continue during acute attacks. 
    • UK: Never commence these during an acute attack, as they may worsen the flare.[9]
    • US: Per ACR, some patients Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clinician–Patient Relationship may benefit from initiating therapy during a flare.[6]

Nonsteroidal antiinflammatory drugs ( NSAIDs NSAIDS Primary vs Secondary Headaches):[6,9,17,21]

  • Naproxen Naproxen An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. Nonsteroidal Antiinflammatory Drugs (NSAIDs) at maximum dosage Dosage Dosage Calculation is suitable. 
  • Aspirin Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. Nonsteroidal Antiinflammatory Drugs (NSAIDs) is not indicated. 
  • Continue treatment for 1–2 days after the attack has resolved. 
  • Consider PPI for gastric protection.
  • Contraindicated in:
    • Active peptic ulcer Peptic ulcer Peptic ulcer disease (PUD) refers to the full-thickness ulcerations of duodenal or gastric mucosa. The ulcerations form when exposure to acid and digestive enzymes overcomes mucosal defense mechanisms. The most common etiologies include Helicobacter pylori (H. pylori) infection and prolonged use of non-steroidal anti-inflammatory drugs (NSAIDs). Peptic Ulcer Disease disease
    • Impaired kidney function
    • Heart failure Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (ventricular dysfunction), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as myocardial infarction. Total Anomalous Pulmonary Venous Return (TAPVR)
    • Coagulopathy

Colchicine Colchicine A major alkaloid from colchicum autumnale l. And found also in other colchicum species. Its primary therapeutic use is in the treatment of gout. Gout Drugs:[6,9,17,21]

  • Dose:
    • 0.5–0.6 mg 2–4 times daily until pain Pain An unpleasant sensation induced by noxious stimuli which are detected by nerve endings of nociceptive neurons. Pain: Types and Pathways relief achieved
    • Recommended regimen:
      • Start with 1–1.2 mg.
      • Follow with 0.5–0.6 mg after 1 hour.
      • Pause for 12 hours. 
      • Resume treatment with 0.5–0.6 mg every 8 hours until symptoms are relieved.
    • Maximum dose per course: 6 mg 
    • Course should not be repeated within 3 days.
  • Has a narrow therapeutic index Therapeutic Index An indicator of the benefits and risks of treatment. Dosage Calculation and is extremely toxic in overdose
  • Contraindicated in severe renal or liver Liver The liver is the largest gland in the human body. The liver is found in the superior right quadrant of the abdomen and weighs approximately 1.5 kilograms. Its main functions are detoxification, metabolism, nutrient storage (e.g., iron and vitamins), synthesis of coagulation factors, formation of bile, filtration, and storage of blood. Liver: Anatomy disease (eGFR <10 mL/min)
  • Drug interactions:

Glucocorticoids Glucocorticoids Glucocorticoids are a class within the corticosteroid family. Glucocorticoids are chemically and functionally similar to endogenous cortisol. There are a wide array of indications, which primarily benefit from the antiinflammatory and immunosuppressive effects of this class of drugs. Glucocorticoids:[6,9,17]

  • Example: oral prednisolone Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Immunosuppressants 30–50 mg once daily for 3–5 days
  • Can be given via IV, IM, oral, or intra-articular routes. 
  • Make sure to rule out septic arthritis Arthritis Acute or chronic inflammation of joints. Osteoarthritis before giving corticosteroids Corticosteroids Chorioretinitis.
  • Consider if NSAIDs NSAIDS Primary vs Secondary Headaches or colchicine Colchicine A major alkaloid from colchicum autumnale l. And found also in other colchicum species. Its primary therapeutic use is in the treatment of gout. Gout Drugs are not tolerated or are contraindicated 

Interleukin-1 Interleukin-1 A soluble factor produced by monocytes; macrophages, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, interleukin-1alpha and interleukin-1beta. The biological effects of il-1 include the ability to replace macrophage requirements for t-cell activation. Interleukins (IL-1) inhibitors:[6,9,21] 

  • Examples:
  • Very expensive
  • Considerations:
    • In the US, IL-1 inhibitors are conditionally recommended over no therapy (beyond supportive/analgesic management) in individuals in whom the above therapies are ineffective, not tolerated, or contraindicated.
    • Canakinumab Canakinumab Immunosuppressants is licensed in Europe by the European Medicines Agency but not in the US by the FDA owing to uncertainty about risks–benefits. 
    • Not recommended by the National Institute for Health and Care Excellence (NICE); off-label prescriptions by a rheumatologist often require funding Funding Conflict of Interest applications.
Management of acute gout algorithm

Algorithm for the management of acute gout

Image by Lecturio.

Referrals[9,12]

  • Seek specialist advice for individuals:
    • In whom septic arthritis Arthritis Acute or chronic inflammation of joints. Osteoarthritis is suspected
    • In whom underlying systemic illness (e.g., rheumatoid arthritis Arthritis Acute or chronic inflammation of joints. Osteoarthritis or connective tissue Connective tissue Connective tissues originate from embryonic mesenchyme and are present throughout the body except inside the brain and spinal cord. The main function of connective tissues is to provide structural support to organs. Connective tissues consist of cells and an extracellular matrix. Connective Tissue: Histology disorder) is suspected
    • Who are pregnant
    • < 30 years of age
    • Who would benefit from intra-articular steroid injection but the facilities or expertise is not available 
    • At risk of adverse effects of drug treatment 
    • With complications of gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout:
      • Chronic arthritis Arthritis Acute or chronic inflammation of joints. Osteoarthritis 
      • Joint damage 
      • Reduced health-related quality Quality Activities and programs intended to assure or improve the quality of care in either a defined medical setting or a program. The concept includes the assessment or evaluation of the quality of care; identification of problems or shortcomings in the delivery of care; designing activities to overcome these deficiencies; and follow-up monitoring to ensure effectiveness of corrective steps. Quality Measurement and Improvement of life 
      • Renal stones 
      • Tophi Tophi Msu deposit in the soft tissue and synovium. Gout 
  • Consider rheumatology referral:
    • Uncertain diagnosis 
    • Response to treatment inadequate 
    • Treatment not tolerated/contraindicated 
    • Patients Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clinician–Patient Relationship with chronic kidney disease Chronic Kidney Disease Chronic kidney disease (CKD) is kidney impairment that lasts for ≥ 3 months, implying that it is irreversible. Hypertension and diabetes are the most common causes; however, there are a multitude of other etiologies. In the early to moderate stages, CKD is usually asymptomatic and is primarily diagnosed by laboratory abnormalities. Chronic Kidney Disease, stage 3b–5 
    • Patients Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clinician–Patient Relationship with organ transplants

Follow-up[9,17]

  • Should occur 4–6 weeks after a flare
  • Measure serum urate. 
  • Reiterate patient education. 
  • Discuss risk and benefits of urate-lowering therapies. 
  • Assess comorbidities Comorbidities The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival. St. Louis Encephalitis Virus, including:
    • Cardiovascular risk factors 
    • Chronic kidney disease Chronic Kidney Disease Chronic kidney disease (CKD) is kidney impairment that lasts for ≥ 3 months, implying that it is irreversible. Hypertension and diabetes are the most common causes; however, there are a multitude of other etiologies. In the early to moderate stages, CKD is usually asymptomatic and is primarily diagnosed by laboratory abnormalities. Chronic Kidney Disease
  • Review medications (e.g., consider switching from diuretics Diuretics Agents that promote the excretion of urine through their effects on kidney function. Heart Failure and Angina Medication to different antihypertensive agents)

Management of Chronic Gout

Management differs for acute and chronic gout Chronic Gout Gout.

The goal of management is to minimize urate deposition in tissues and to prevent disease flares. 

General measures[10,17]

  • Weight loss Weight loss Decrease in existing body weight. Bariatric Surgery to achieve BMI BMI An indicator of body density as determined by the relationship of body weight to body height. Bmi=weight (kg)/height squared (m2). Bmi correlates with body fat (adipose tissue). Their relationship varies with age and gender. For adults, bmi falls into these categories: below 18. 5 (underweight); 18. 5-24. 9 (normal); 25. 0-29. 9 (overweight); 30. 0 and above (obese). Obesity < 25
  • Avoid foods with a high purine content (e.g., seafood, meat, alcohol [varies among different beverages])
  • Avoid certain medications that cause hyperuricemia Hyperuricemia Excessive uric acid or urate in blood as defined by its solubility in plasma at 37 degrees c; greater than 0. 42 mmol per liter (7. 0 mg/dl) in men or 0. 36 mmol per liter (6. 0 mg/dl) in women. Gout
    • Diuretics Diuretics Agents that promote the excretion of urine through their effects on kidney function. Heart Failure and Angina Medication both increase urate reabsorption and decrease its secretion Secretion Coagulation Studies.
    • Allopurinol Allopurinol A xanthine oxidase inhibitor that decreases uric acid production. It also acts as an antimetabolite on some simpler organisms. Gout Drugs is often administered to control gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout if a diuretic is necessary.

Medical treatment

Indications:[6,10,21]

  • Recurrent attacks (≥ 2 per year)
  • Tophi Tophi Msu deposit in the soft tissue and synovium. Gout
  • Radiographic evidence of bone Bone Bone is a compact type of hardened connective tissue composed of bone cells, membranes, an extracellular mineralized matrix, and central bone marrow. The 2 primary types of bone are compact and spongy. Bones: Structure and Types damage attributed to gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout
  • 1st gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout flare and:
    • Chronic kidney disease Chronic Kidney Disease Chronic kidney disease (CKD) is kidney impairment that lasts for ≥ 3 months, implying that it is irreversible. Hypertension and diabetes are the most common causes; however, there are a multitude of other etiologies. In the early to moderate stages, CKD is usually asymptomatic and is primarily diagnosed by laboratory abnormalities. Chronic Kidney Disease stage 3–5
    • Uric acid Uric acid An oxidation product, via xanthine oxidase, of oxypurines such as xanthine and hypoxanthine. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals urate oxidase further oxidizes it to allantoin. Nephrolithiasis level > 9 mg/dL
    • Urolithiasis 

Mechanism of action for xanthine oxidase Oxidase Neisseria inhibitors:[4,6]

  • Uric acid Uric acid An oxidation product, via xanthine oxidase, of oxypurines such as xanthine and hypoxanthine. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals urate oxidase further oxidizes it to allantoin. Nephrolithiasis production by inhibiting xanthine oxidase Oxidase Neisseria (an enzyme involved in endogenous purine synthesis Synthesis Polymerase Chain Reaction (PCR)).
  • Benefits:
    • Eliminate urate crystals
    • Prevent flares
    • Shrink tophi Tophi Msu deposit in the soft tissue and synovium. Gout 
    • Protect against joint damage

Dosing:[6,10,17,21] 

  • Allopurinol Allopurinol A xanthine oxidase inhibitor that decreases uric acid production. It also acts as an antimetabolite on some simpler organisms. Gout Drugs:
    • Typically, the preferred 1st-line agent
    • Start with 100 mg daily (taken after food).
    • Adjust in 100-mg increments every 4 weeks according to serum urate. 
    • Amounts > 300 mg should be taken in divided doses.
    • In severe renal impairment, either:
      • Reduce daily dose below 100 mg, or
      • Increase dosing interval 
  • Febuxostat Febuxostat A thiazole derivative and inhibitor of xanthine oxidase that is used for the treatment of hyperuricemia in patients with chronic gout. Gout Drugs:
    • Starting dose of 40–80 mg or less daily for 2–4 weeks 
    • Increase dose every 2–5 weeks, up to a maximum dose of 120 mg daily 
    • Dose adjustment to a maximum of 80 mg in hepatic impairment 
    • Prescribe for ≥ 6 months 

Considerations:[6,10,17]

  • Offer allopurinol Allopurinol A xanthine oxidase inhibitor that decreases uric acid production. It also acts as an antimetabolite on some simpler organisms. Gout Drugs as 1st-line therapy in patients Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clinician–Patient Relationship with major cardiovascular disease (e.g., stroke, myocardial infarction Myocardial infarction MI is ischemia and death of an area of myocardial tissue due to insufficient blood flow and oxygenation, usually from thrombus formation on a ruptured atherosclerotic plaque in the epicardial arteries. Clinical presentation is most commonly with chest pain, but women and patients with diabetes may have atypical symptoms. Myocardial Infarction, unstable angina Unstable angina Precordial pain at rest, which may precede a myocardial infarction. Stable and Unstable Angina)
  • Initiation recommendations vary:
    • US: ACR conditionally recommends initiating during the gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout flare for certain patients Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clinician–Patient Relationship.[6]
    • UK: Commence at least 2–4 weeks after gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout flare settles.[10]
  • Start with low doses and titrate up based on monthly serum urate concentration.

Monitoring and screening Screening Preoperative Care:[6,10,17,19,21]

  • Monitor for hypersensitivity syndrome when starting allopurinol Allopurinol A xanthine oxidase inhibitor that decreases uric acid production. It also acts as an antimetabolite on some simpler organisms. Gout Drugs.
  • Consider screening Screening Preoperative Care for HLA-B HLA-B Class I human histocompatibility (HLA) surface antigens encoded by more than 30 detectable alleles on locus B of the HLA complex, the most polymorphic of all the HLA specificities. Several of these antigens (e.g., hla-b27, -b7, -b8) are strongly associated with predisposition to rheumatoid and other autoimmune disorders. Like other class I HLA determinants, they are involved in the cellular immune reactivity of cytolytic T lymphocytes. Organ Transplantation*5801 before starting allopurinol Allopurinol A xanthine oxidase inhibitor that decreases uric acid production. It also acts as an antimetabolite on some simpler organisms. Gout Drugs in subgroups with high prevalence Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from incidence, which refers to the number of new cases in the population at a given time. Measures of Disease Frequency of the allele Allele Variant forms of the same gene, occupying the same locus on homologous chromosomes, and governing the variants in production of the same gene product. Basic Terms of Genetics (e.g., Han Chinese, Thai, Korean)
    • Associated with risk of allopurinol Allopurinol A xanthine oxidase inhibitor that decreases uric acid production. It also acts as an antimetabolite on some simpler organisms. Gout Drugs hypersensitivity, Stevens-Johnson syndrome Stevens-Johnson syndrome Stevens-Johnson syndrome (SJS) is a cutaneous, immune-mediated hypersensitivity reaction that is commonly triggered by medications, including antiepileptics and antibiotics. The condition runs on a spectrum with toxic epidermal necrolysis (TEN) based on the amount of body surface area (BSA) involved. Stevens-Johnson Syndrome, and toxic epidermal necrolysis Toxic Epidermal Necrolysis Stevens-Johnson Syndrome 
    • Do not prescribe to people known to have this allele Allele Variant forms of the same gene, occupying the same locus on homologous chromosomes, and governing the variants in production of the same gene product. Basic Terms of Genetics
  • Monitor liver Liver The liver is the largest gland in the human body. The liver is found in the superior right quadrant of the abdomen and weighs approximately 1.5 kilograms. Its main functions are detoxification, metabolism, nutrient storage (e.g., iron and vitamins), synthesis of coagulation factors, formation of bile, filtration, and storage of blood. Liver: Anatomy function periodically before and while taking febuxostat Febuxostat A thiazole derivative and inhibitor of xanthine oxidase that is used for the treatment of hyperuricemia in patients with chronic gout. Gout Drugs.
  • Monitor serum urate:
    • Aim for target serum urate < 360 µmol/L (6 mg/dL)
    • Consider lower target serum urate (< 300 µmol/L (5 mg/dL)) for people with:
      • Tophi Tophi Msu deposit in the soft tissue and synovium. Gout 
      • Chronic gouty arthritis Arthritis Acute or chronic inflammation of joints. Osteoarthritis 
      • Ongoing frequent flares
    • Once target urate levels are reached, consider annual monitoring. 

Other medication options:[6,10,17,21] 

  • Probenecid Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Gout Drugs:
    • Uricosuric drug that inhibits tubular reabsorption of urate → ↑ urinary uric acid Uric acid An oxidation product, via xanthine oxidase, of oxypurines such as xanthine and hypoxanthine. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals urate oxidase further oxidizes it to allantoin. Nephrolithiasis excretion and ↓ serum urate concentration 
    • Unlicensed in the UK and available only off-license to named patients Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clinician–Patient Relationship under the care of a rheumatologist.
    • In the US, a trial of probenecid Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Gout Drugs can be started if allopurinol Allopurinol A xanthine oxidase inhibitor that decreases uric acid production. It also acts as an antimetabolite on some simpler organisms. Gout Drugs and febuxostat Febuxostat A thiazole derivative and inhibitor of xanthine oxidase that is used for the treatment of hyperuricemia in patients with chronic gout. Gout Drugs are not tolerated or are contraindicated.
      • Note: This is not recommended for patients Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clinician–Patient Relationship with moderate-to-severe CKD CKD Chronic kidney disease (CKD) is kidney impairment that lasts for ≥ 3 months, implying that it is irreversible. Hypertension and diabetes are the most common causes; however, there are a multitude of other etiologies. In the early to moderate stages, CKD is usually asymptomatic and is primarily diagnosed by laboratory abnormalities. Chronic Kidney Disease (stage ≥ 3).
      • An initial dose of 500 mg 1–2 times daily is conditionally recommended.
  • Pegloticase Pegloticase Gout Drugs:
    • A recombinant pegylated (i.e., linked to methoxy polyethylene glycol Polyethylene Glycol Laxatives) uricase → uric acid Uric acid An oxidation product, via xanthine oxidase, of oxypurines such as xanthine and hypoxanthine. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals urate oxidase further oxidizes it to allantoin. Nephrolithiasis metabolized to allantoin → less likely to precipitate
    • Not currently recommended by NICE 
    • ACR and European League Against Rheumatism (EULAR) recommend pegloticase Pegloticase Gout Drugs in patients Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clinician–Patient Relationship with severe, treatment-refractory gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout (> 2 flares per year or nonresolving tophi Tophi Msu deposit in the soft tissue and synovium. Gout).
    • Warnings against high cost and adverse effects
    • Should not be used as a 1st-line agent

Antiinflammatory prophylaxis Prophylaxis Cephalosporins:[6,10,17]

  • Concomitant therapy with antiinflammatory medications is recommended to prevent flares during initiation of urate-lowering therapy.
  • Choice should be based on patient factors, but may include:
    • Colchicine Colchicine A major alkaloid from colchicum autumnale l. And found also in other colchicum species. Its primary therapeutic use is in the treatment of gout. Gout Drugs
    • NSAIDs NSAIDS Primary vs Secondary Headaches
    • Glucocorticoids Glucocorticoids Glucocorticoids are a class within the corticosteroid family. Glucocorticoids are chemically and functionally similar to endogenous cortisol. There are a wide array of indications, which primarily benefit from the antiinflammatory and immunosuppressive effects of this class of drugs. Glucocorticoids (e.g., prednisone Prednisone A synthetic anti-inflammatory glucocorticoid derived from cortisone. It is biologically inert and converted to prednisolone in the liver. Immunosuppressants or prednisolone Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Immunosuppressants)
  • Recommended duration of 3–6 months after initiating urate-lowering therapy with ongoing reevaluation (continue prophylaxis Prophylaxis Cephalosporins if flares continue)

Patient education:[6,10] 

  • Therapy is continued indefinitely, even after target serum urate level is achieved. 
  • Usually requires lifelong treatment 
  • Seek advice for acute flares 
Gout management diagram

Summary of the pathophysiology and drugs used for gout

Image by Lecturio.

Differential Diagnosis

The following conditions are differential diagnoses of gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout:

  • Septic arthritis Arthritis Acute or chronic inflammation of joints. Osteoarthritis: an infection of a joint with extremely high WBC counts in synovial fluid (> 100,000 cells/mL) are most supportive of a diagnosis of septic arthritis Arthritis Acute or chronic inflammation of joints. Osteoarthritis. Gram stain Gram stain Klebsiella and synovial fluid culture are performed for diagnosis.
  • Calcium Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Electrolytes pyrophosphate crystal deposition disease (CPPD, pseudogout): positively birefringent crystals in synovial fluid. Calcium Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Electrolytes pyrophosphate crystal deposition disease also has a characteristic radiographic appearance of chondrocalcinosis Chondrocalcinosis Presence of calcium pyrophosphate in the connective tissues such as the cartilaginous structures of joints. When accompanied by gout-like symptoms, it is referred to as pseudogout. Gitelman Syndrome
  • Trauma: a stress fracture Fracture A fracture is a disruption of the cortex of any bone and periosteum and is commonly due to mechanical stress after an injury or accident. Open fractures due to trauma can be a medical emergency. Fractures are frequently associated with automobile accidents, workplace injuries, and trauma. Overview of Bone Fractures or traumatic process in the bone Bone Bone is a compact type of hardened connective tissue composed of bone cells, membranes, an extracellular mineralized matrix, and central bone marrow. The 2 primary types of bone are compact and spongy. Bones: Structure and Types or joint can mimic a gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout flare.
  • Cellulitis Cellulitis Cellulitis is a common infection caused by bacteria that affects the dermis and subcutaneous tissue of the skin. It is frequently caused by Staphylococcus aureus and Streptococcus pyogenes. The skin infection presents as an erythematous and edematous area with warmth and tenderness. Cellulitis: a common and painful bacterial skin Skin The skin, also referred to as the integumentary system, is the largest organ of the body. The skin is primarily composed of the epidermis (outer layer) and dermis (deep layer). The epidermis is primarily composed of keratinocytes that undergo rapid turnover, while the dermis contains dense layers of connective tissue. Skin: Structure and Functions infection that affects the deeper layers of the dermis Dermis A layer of vascularized connective tissue underneath the epidermis. The surface of the dermis contains innervated papillae. Embedded in or beneath the dermis are sweat glands; hair follicles; and sebaceous glands. Skin: Structure and Functions and subcutaneous tissue Subcutaneous tissue Loose connective tissue lying under the dermis, which binds skin loosely to subjacent tissues. It may contain a pad of adipocytes, which vary in number according to the area of the body and vary in size according to the nutritional state. Soft Tissue Abscess. Typical signs of acute inflammation Acute Inflammation Inflammation ( rubor Rubor Inflammation, dolor Dolor Inflammation, calor Calor Inflammation, tumor Tumor Inflammation) are present but joint mobility is usually preserved.
  • Rheumatoid arthritis Arthritis Acute or chronic inflammation of joints. Osteoarthritis: an autoimmune inflammatory polyarthritis Polyarthritis Rheumatoid Arthritis. Tophi Tophi Msu deposit in the soft tissue and synovium. Gout may be mistaken for rheumatoid nodules Rheumatoid Nodules Rheumatoid Arthritis but the clinicoradiological presentation and the lack of crystals in the nodular lesions can differentiate the 2 conditions.
  • Dactylitis Dactylitis Ankylosing Spondylitis: severe bacterial inflammation Inflammation Inflammation is a complex set of responses to infection and injury involving leukocytes as the principal cellular mediators in the body’s defense against pathogenic organisms. Inflammation is also seen as a response to tissue injury in the process of wound healing. The 5 cardinal signs of inflammation are pain, heat, redness, swelling, and loss of function. Inflammation of the finger and toe joints that can resemble tophaceous gout Tophaceous gout Nodular deposit of monosodium urate crystals associated with chronic inflammation with a foreign-body giant cell reaction. Gout with acute flare. The condition can usually be distinguished from gout Gout Gout is a heterogeneous metabolic disease associated with elevated serum uric acid levels (> 6.8 mg/dL) and abnormal deposits of monosodium urate in tissues. The condition is often familial and is initially characterized by painful, recurring, and usually monoarticular acute arthritis, or “gout flare,” followed later by chronic deforming arthritis. Gout based on the history and physical examination.
  • Osteomyelitis Osteomyelitis Osteomyelitis is an infection of the bone that results from the spread of microorganisms from the blood (hematogenous), nearby infected tissue, or open wounds (non-hematogenous). Infections are most commonly caused by Staphylococcus aureus. Osteomyelitis: an infection (usually bacterial) of the bone Bone Bone is a compact type of hardened connective tissue composed of bone cells, membranes, an extracellular mineralized matrix, and central bone marrow. The 2 primary types of bone are compact and spongy. Bones: Structure and Types. Diagnosis is made by noting deep bony tenderness and clinical signs of acute systemic inflammation Systemic Inflammation Surgical Site Infections; CBC and magnetic resonance imaging (MRI) are helpful if routine radiologic findings are not supportive.
  • Basic calcium Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Electrolytes phosphate Phosphate Inorganic salts of phosphoric acid. Electrolytes (BCP) crystal disease (hydroxyapatite ( HA HA Hemolytic anemia (HA) is the term given to a large group of anemias that are caused by the premature destruction/hemolysis of circulating red blood cells (RBCs). Hemolysis can occur within (intravascular hemolysis) or outside the blood vessels (extravascular hemolysis). Hemolytic Anemia) crystal deposition disease): painful and probably underdiagnosed periarthritis or arthritis Arthritis Acute or chronic inflammation of joints. Osteoarthritis due to the deposition of BCP crystals in the synovium. The condition can cause severe joint damage, as in the Milwaukee shoulder syndrome seen in elderly women.

References

  1. Horvai, H. (2020). In Kumar, V., Abbas, A. K., Aster, J. C., (Eds.), Robbins & Cotran Pathologic Basis of Disease. (10th ed., pp. 1204–1206). Elsevier.
  2. Juraschek, S. P., Miller, E. R. 3rd, Gelber, A. C. (2013). Body mass index, obesity, and prevalent gout in the United States in 1988–1994 and 2007–2010. Arthritis Care & Research (Hoboken), 65(1), 127–132. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482278/
  3. Gaffo, A. L. (2019). Clinical manifestations and diagnosis of gout. UpToDate. Retrieved August 31, 2020, from https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-gout#H87540416
  4. Schumacher, H. R., Chen, L. X. (2018). In Jameson, J. L., et al. (Eds.), Harrison’s Principles of Internal Medicine (20th ed., vol. 2, pp. 2631–2633). 
  5. Le, T., Bhusan, V., Sochat, M., et al. (Eds.) (2020). First aid for the USMLE Step 1 (30th ed., p. 467). 
  6. FitzGerald, J. D., Dalbeth, N. et al. (2020). 2020 American College of Rheumatology guideline for management of gout. Arthritis and Rheumatology, 72(6), 879–895. https://deepblue.lib.umich.edu/handle/2027.42/155484
  7. Gaffo, A. L. (2019). Treatment of gout flares. UpToDate. Retrieved August 3, 2022, from https://www.uptodate.com/contents/treatment-of-gout-flares
  8. Fernando, P. R. (2022). Pharmacologic urate-lowering therapy and treatment of tophi in patients with gout. UpToDate. Retrieved August 3, 2022, from https://www.uptodate.com/contents/pharmacologic-urate-lowering-therapy-and-treatment-of-tophi-in-patients-with-gout
  9. National Institute for Health and Care Excellence. (2018). Acute gout: management Retrieved August 3, 2022, from https://cks.nice.org.uk/topics/gout/management/acute-gout/
  10. National Institute for Health and Care Excellence. (2018). Preventing gout: management Retrieved August 3, 2022, from https://cks.nice.org.uk/topics/gout/management/preventing-gout/
  11. National Institute for Health and Care Excellence. (2018). Gout: diagnosis: assessment. Retrieved August 3, 2022, from https://cks.nice.org.uk/topics/gout/diagnosis/assessment/
  12. National Institute for Health and Care Excellence (2018). Gout: complications. Retrieved August 3, 2022, from https://cks.nice.org.uk/topics/gout/background-information/complications/
  13. National Institute for Health and Care Excellence (2018). Gout: differential diagnosis. Retrieved August 3, 2022, from https://cks.nice.org.uk/topics/gout/diagnosis/differential-diagnosis/
  14. Neogi, T., Jansen, T. L., et al. (2015). 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis and Rheumatology, 67(10), 2557–2568. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566153/
  15. National Institute for Health and Care Excellence. (2018). Gout: causes and risk factors. Retrieved August 3, 2022, from https://cks.nice.org.uk/topics/gout/background-information/causes-risk-factors/
  16. Merriman, T. (2022). Pathophysiology of gout. UpToDate. Retrieved August 31, 2020, from https://www.uptodate.com/contents/pathophysiology-of-gout
  17. Hui, M., Carr, A., et al. (2017). The British Society for Rheumatology guideline for the management of gout. Rheumatology, 56(7), e1–e20. https://academic.oup.com/rheumatology/article/56/7/e1/3855179?login=false
  18. Bursill, D., et al. (2019). Gout, hyperuricemia, and Crystal-Associated Disease Network consensus statement regarding labels and definitions for disease elements in gout. Arthritis Care & Research, 71(3), 427–434. https://onlinelibrary.wiley.com/doi/epdf/10.1002/acr.23607
  19. Hershfield, M. S., et al. (2013). Clinical pharmacogenetics implementation consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing. Clinical Pharmacology & Therapeutics, 93(2), 153–158. https://files.cpicpgx.org/data/guideline/publication/allopurinol/2013/23232549.pdf
  20. Richette, P., et al. (2018). 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Annals of the Rheumatic Diseases, 79, 31–38. https://ard.bmj.com/content/79/1/31
  21. Richette, P., et al. (2017). 2016 updated EULAR evidence-based recommendations for the management of gout. Annals of the Rheumatic Diseases, 76, 29–42. https://ard.bmj.com/content/76/1/29

Create your free account or log in to continue reading!

Sign up now and get free access to Lecturio with concept pages, medical videos, and questions for your medical education.

User Reviews

Details